© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
June 20, 2018
Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.
September's Top 5 Infectious Disease Stories
COVID-19 Vaccine Boosters: Roadblocks, the Future, and Communicating the Benefits to Patients
CDC Updates Pneumococcal Conjugate Vaccine Recommendations
Shionogi Reaches Endpoint for Phase 3 COVID-19 Pill